trypan blue has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, JM; Bukusi, EA; Cohen, CR; Harrison, WG; Hemmerling, A; Moscicki, B; Oziemkowska, M | 1 |
| Armati, PJ; Brew, BJ; Kerr, SJ; Pemberton, LA; Smythe, G; Tattam, B | 1 |
2 other study(ies) available for trypan blue and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Trypan blue staining to determine vaginal exposure in two types of plastic vaginal applicators containing two different microbicide formulations.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intravaginal; Adult; Anti-Infective Agents; Coloring Agents; Drug Delivery Systems; Female; Humans; Medication Adherence; Polyethylene; Polypropylenes; Staining and Labeling; Surface Properties; Trypan Blue; Vagina | 2012 |
Kynurenine pathway inhibition reduces neurotoxicity of HIV-1-infected macrophages.
Topics: Acquired Immunodeficiency Syndrome; Brain; Cell Aggregation; Cells, Cultured; Coloring Agents; Fetus; HIV-1; Humans; Immunohistochemistry; Kynurenine; L-Lactate Dehydrogenase; Macrophages; Microscopy, Electron; Quinolinic Acid; Trypan Blue; Tryptophan | 1997 |